Shi Yu, Pu Shi, Peng Hongmei, Zhang Jing, Li Yang, Huang Xia, Song Caiping, Luo Yu
Department of Nephrology, The Second Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing, 400037, P.R. China.
Thinmed Medical Technology (Chongqing) Co.,LTD, Chongqing, 401121, P.R. China.
BMC Med Inform Decis Mak. 2024 Jun 12;24(1):163. doi: 10.1186/s12911-024-02567-3.
Chronic kidney disease (CKD) is a significant public health concern, and patient self-management is an effective approach to manage the condition. Mobile applications have been used as tools to assist in improving patient self-management, but their effectiveness in long-term outpatient follow-up management of patients with CKD remains to be validated. This study aimed to investigate whether using a mobile application combined with traditional outpatient follow-up can improve health outcomes of patients with CKD .
This retrospective cohort study recruited CKD patients with stage 1-5 who were not receiving renal replacement therapy from a CKD management center. Two groups were established: the APP + outpatient follow-up group and the traditional outpatient follow-up group. Baseline data was collected from January 2015 to December 2019, followed by a three-year long-term follow-up until December 2022. Laboratory data, all-cause mortality, and renal replacement treatment were then collected and compared between the two groups.
5326 patients were included in the study, including 2492 in the APP + outpatient group and 2834 in the traditional outpatient group. After IPTW virtualization matching, the final matched the APP + outpatient group consisted of 2489 cases (IQR, 33-55) and 2850 (IQR, 33-55) in the traditional outpatient group. By the end of the study, it was observed that the laboratory data of Phosphorus, Sodium, Triglyceride, Hemoglobin showed significant improvements, Furthermore the APP + outpatient group demonstrated superior results compared to the traditional outpatient group (P < .05). And it was observed that there were 34 deaths (1.4%) in the APP + outpatient group and 46 deaths (1.6%) in the traditional outpatient group(P = .49). After matching for renal replacement therapy outcomes, the two groups were found to be comparable (95% CI [0.72-1.08], P = .23), with no significant difference. However, it was noted that the traditional outpatient group had a lower incidence of using temporary catheters during initial hemodialysis (95% CI [8.4-29.8%], P < .001).
The development and application of an app combined with outpatient follow-up management can improve patient health outcomes. However, to ensure optimal preparation for kidney replacement therapy, patients in CKD stages 4-5 may require more frequent traditional outpatient follow-ups, and further develop an information-based decision-making support tool for renal replacement therapy.
慢性肾脏病(CKD)是一个重大的公共卫生问题,患者自我管理是控制该病的有效方法。移动应用程序已被用作辅助改善患者自我管理的工具,但其在CKD患者长期门诊随访管理中的有效性仍有待验证。本研究旨在调查使用移动应用程序结合传统门诊随访是否能改善CKD患者的健康结局。
这项回顾性队列研究招募了来自CKD管理中心的1-5期未接受肾脏替代治疗的CKD患者。设立了两组:APP+门诊随访组和传统门诊随访组。收集2015年1月至2019年12月的基线数据,随后进行为期三年的长期随访直至2022年12月。然后收集并比较两组的实验室数据、全因死亡率和肾脏替代治疗情况。
本研究共纳入5326例患者,其中APP+门诊组2492例,传统门诊组2834例。经过IPTW虚拟化匹配后,最终匹配的APP+门诊组有2489例(IQR,33-55),传统门诊组有2850例(IQR,33-55)。到研究结束时,观察到磷、钠、甘油三酯、血红蛋白的实验室数据有显著改善,此外,APP+门诊组的结果优于传统门诊组(P<0.05)。观察到APP+门诊组有34例死亡(1.4%),传统门诊组有46例死亡(1.6%)(P=0.49)。在对肾脏替代治疗结局进行匹配后,发现两组具有可比性(95%CI[0.72-1.08],P=0.23),无显著差异。然而,注意到传统门诊组在初始血液透析期间使用临时导管的发生率较低(95%CI[8.4-29.8%],P<0.001)。
结合门诊随访管理的应用程序的开发和应用可以改善患者的健康结局。然而,为确保肾脏替代治疗的最佳准备,4-5期CKD患者可能需要更频繁的传统门诊随访,并进一步开发用于肾脏替代治疗的基于信息的决策支持工具。